Loading clinical trials...
Loading clinical trials...
Docetaxel, Cisplatin and Fluorouracil Combination in the Neoadjuvant Treatment of Locally Advanced Gastric Adenocarcinoma : Phase II Clinical Study
Conditions
Interventions
Docetaxel
Cisplatin
+1 more
Locations
1
Turkey (Türkiye)
Sanofi-Aventis Administrative Office
Istanbul, Turkey (Türkiye)
Start Date
June 1, 2006
Primary Completion Date
March 1, 2012
Completion Date
March 1, 2012
Last Updated
November 4, 2014
NCT06885697
NCT06630130
NCT07035587
NCT01649271
NCT02310230
NCT06260150
Lead Sponsor
Sanofi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions